Skip to main content
Clinical Trials/NCT06443996
NCT06443996
Enrolling by Invitation
N/A

Effects of Sleep Quality and Mental Status on Early Postoperative Recurrence and Prognosis in Patients With Colorectal Cancer: a Prospective Observational Cohort Study

Ma Yanlei1 site in 1 country500 target enrollmentAugust 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Ma Yanlei
Enrollment
500
Locations
1
Primary Endpoint
Effect of sleep quality and mental state on early recurrence and prognosis of patients with colorectal cancer after surgery
Status
Enrolling by Invitation
Last Updated
last year

Overview

Brief Summary

This is a prospective observational cohort study to explore the effects of sleep quality and mental status on early postoperative recurrence and prognosis in patients with colorectal cancer.

Detailed Description

Evidence of evidence-based medicine shows that patients with malignant tumors have heavy psychological pressure after disease, and are prone to different degrees of sleep disorders and mental health problems, which often affect the progression and prognosis of the primary tumor. Previous studies have reported that baseline sleep quality was independently associated with risk of progression, risk of death, and response to treatment in patients with metastatic colorectal cancer before and during chemotherapy. Surgery, as a stressor, often causes obvious psychological stress reactions in patients, resulting in varying degrees of sleep disorders and poor mental performance, which may also become a factor affecting the recurrence and prognosis of patients. Therefore, the Department of Colorectal Surgery, Affiliated Cancer Hospital of Fudan University intends to conduct a prospective observational cohort study on the effects of sleep quality and mental state on early postoperative recurrence and prognosis of patients with colorectal cancer, in order to explore the effects of sleep quality and mental state on early postoperative recurrence and prognosis of patients with colorectal cancer.

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
December 31, 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Ma Yanlei
Responsible Party
Sponsor Investigator
Principal Investigator

Ma Yanlei

Chief physician

Fudan University

Eligibility Criteria

Inclusion Criteria

  • Preoperative fibrocolonoscopy and pathological examination confirmed colorectal cancer;
  • Age 18 \~ 80 years old;
  • Baseline clinical stage TNM Ⅰ to Ⅲ : cT1-4N0-2M0 (AJCC-8 version);
  • The United States Eastern Oncology Consortium (ECOG) physical status score was 0 to 2 points;
  • Laboratory examination results before admission met the following surgical conditions: neutrophil (ANC) ≥1.5×109/L, platelets (PLT) ≥ 100×109/L, total bilirubin (TBI) ≤1.5× upper limit of normal (2mg/dl), alanine aminotransferase (ALT), aspartate aminotransferase (AST) ≤2× upper limit of normal; Coagulation parameters in the normal range;
  • Able to complete the required research questionnaire independently or with the assistance of the researcher;
  • Patients were willing to undergo regular follow-up after surgery and had no psychological, family, social, or geographic constraints that affected protocol compliance and follow-up time;
  • Patients and their families can understand and are willing to participate in this clinical study, and sign informed consent.

Exclusion Criteria

  • Under 18 years of age or over 80 years of age;
  • Have a family history of severe mental illness;
  • People with mental illness or intellectual disability who cannot correctly describe their feelings;
  • The patient has severe systemic infection;
  • No radical operation was performed during the operation due to various reasons;
  • Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, peritonitis, etc. requiring emergency surgery;
  • Merge other parts of the transfer;
  • Have serious heart, lung, liver and kidney diseases, can not tolerate surgery;
  • Active stage of liver disease or abnormal liver function, ALT, AST, TBIL is more than 2 times the upper limit of normal value;
  • Renal function damage, Cr ≥ 2 times the upper limit of normal value or BUN ≥ 2 times the upper limit of normal value;

Outcomes

Primary Outcomes

Effect of sleep quality and mental state on early recurrence and prognosis of patients with colorectal cancer after surgery

Time Frame: through study completion, an average of 1 year

The correlation of GAD-7 scale score, PHQ-9 scale score and ESAS scale score with Disease-free survival (DFS), Overall Survival and tumor-free survival rate of patients was analyzed

Disease-free survival (DFS)

Time Frame: through study completion, an average of 1 year

The duration between the date after surgery to the date of any recurrence or death firstly

Overall Survival

Time Frame: through study completion, an average of 1 year

Time from the start of surgical randomization to death (from any cause)

Secondary Outcomes

  • Physical examination was used to determine recurrence in patients with colorectal cancer(From date of randomization until the date of death from any cause, whichever came first, assessed up to 100 months)
  • Enteroscope was used to determine recurrence in patients with colorectal cancer enrolled in the study.(From date of randomization until the date of death from any cause, whichever came first, assessed up to 100 months)
  • Tumor markers CEA, CA19-9 was used to determine recurrence in patients with colorectal cancer enrolled in the study.(From date of randomization until the date of death from any cause, whichever came first, assessed up to 100 months)

Study Sites (1)

Loading locations...

Similar Trials